523 related articles for article (PubMed ID: 31100603)
1. Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review.
Ya K; Tangamornsuksan W; Scholfield CN; Methaneethorn J; Lohitnavy M
Asian J Psychiatr; 2019 Jun; 43():73-82. PubMed ID: 31100603
[TBL] [Abstract][Full Text] [Related]
2. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
[TBL] [Abstract][Full Text] [Related]
3. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: present knowledge and future directions in perspective of pain.
Ramachandram DS; Damodaran T; Zainal H; Murugaiyah V; Ramanathan S
J Basic Clin Physiol Pharmacol; 2019 Oct; 31(1):. PubMed ID: 31665120
[TBL] [Abstract][Full Text] [Related]
5. Development of a Physiologically Based Pharmacokinetic Model of Mitragynine, Psychoactive Alkaloid in Kratom (
Ya K; Methaneethorn J; Tran QB; Trakulsrichai S; Wananukul W; Lohitnavy M
J Psychoactive Drugs; 2021; 53(2):127-139. PubMed ID: 34003732
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Safety of Mitragynine in Beagle Dogs.
Maxwell EA; King TI; Kamble SH; Raju KSR; Berthold EC; León F; Avery BA; McMahon LR; McCurdy CR; Sharma A
Planta Med; 2020 Nov; 86(17):1278-1285. PubMed ID: 32693425
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mitragynine in man.
Trakulsrichai S; Sathirakul K; Auparakkitanon S; Krongvorakul J; Sueajai J; Noumjad N; Sukasem C; Wananukul W
Drug Des Devel Ther; 2015; 9():2421-9. PubMed ID: 25995615
[TBL] [Abstract][Full Text] [Related]
8. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
Fowble KL; Musah RA
Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
10. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.
Tanna RS; Tian DD; Cech NB; Oberlies NH; Rettie AE; Thummel KE; Paine MF
J Pharmacol Exp Ther; 2021 Jan; 376(1):64-73. PubMed ID: 33093187
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical Characterization of Mitragyna speciosa Alkaloid Extract and Mitragynine using In Vitro High Throughput Assays.
Kong WM; Chik Z; Mohamed Z; Alshawsh MA
Comb Chem High Throughput Screen; 2017; 20(9):796-803. PubMed ID: 29076424
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats.
Kamble SH; Berthold EC; King TI; Raju Kanumuri SR; Popa R; Herting JR; León F; Sharma A; McMahon LR; Avery BA; McCurdy CR
J Nat Prod; 2021 Apr; 84(4):1104-1112. PubMed ID: 33620222
[TBL] [Abstract][Full Text] [Related]
13. An in vitro evaluation of kratom (Mitragyna speciosa) on the catalytic activity of carboxylesterase 1 (CES1).
Melchert PW; Zhang Q; Mukhopadhyay S; Kanumuri SRR; McCurdy CR; Markowitz JS
Chem Biol Interact; 2023 Oct; 384():110715. PubMed ID: 37716419
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of kratom opioids.
Kim K; Shahsavarani M; Garza-García JJO; Carlisle JE; Guo J; De Luca V; Qu Y
New Phytol; 2023 Oct; 240(2):757-769. PubMed ID: 37518950
[TBL] [Abstract][Full Text] [Related]
15. Metabolite and Molecular Characterization of
Laforest LC; Kuntz MA; Kanumuri SRR; Mukhopadhyay S; Sharma A; O'Connor SE; McCurdy CR; Nadakuduti SS
J Nat Prod; 2023 Apr; 86(4):1042-1052. PubMed ID: 36913648
[TBL] [Abstract][Full Text] [Related]
16. Metabolism studies of the Kratom alkaloids mitraciliatine and isopaynantheine, diastereomers of the main alkaloids mitragynine and paynantheine, in rat and human urine using liquid chromatography-linear ion trap-mass spectrometry.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1049-55. PubMed ID: 21450536
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline.
Manda VK; Avula B; Ali Z; Khan IA; Walker LA; Khan SI
Planta Med; 2014 May; 80(7):568-76. PubMed ID: 24841968
[TBL] [Abstract][Full Text] [Related]
18. Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products.
Manwill PK; Flores-Bocanegra L; Khin M; Raja HA; Cech NB; Oberlies NH; Todd DA
Planta Med; 2022 Aug; 88(9-10):838-857. PubMed ID: 35468648
[TBL] [Abstract][Full Text] [Related]
19. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
[TBL] [Abstract][Full Text] [Related]
20. The effects of chronic mitragynine (Kratom) exposure on the EEG in rats.
Suhaimi FW; Hassan Z; Mansor SM; Müller CP
Neurosci Lett; 2021 Feb; 745():135632. PubMed ID: 33444671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
